Clarius Group, LLC Nautilus Biotechnology, Inc. Transaction History
Clarius Group, LLC
- $1.64 Billion
- Q3 2025
A detailed history of Clarius Group, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 1,209,646 shares of NAUT stock, worth $1.48 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,209,646
Previous 1,060,460
14.07%
Holding current value
$1.48 Million
Previous $763,000
33.16%
% of portfolio
0.06%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding NAUT
# of Institutions
75Shares Held
63.4MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$19.9 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$15.4 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$8.75 Million0.16% of portfolio
-
Madrona Venture Group, LLC6.02MShares$7.35 Million34.58% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$4.67 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $152M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...